Biofrontera AG
D-51377 Leverkusen Germany
February 13, 2020
VIA EDGAR AND EMAIL
Paul Fischer
Division of Corporation Finance, Office of Life Sciences
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549-4561
Re: | Biofrontera AG | |
Registration Statement on Form F-3 | ||
File No. 333-236021 |
Acceleration Request | ||
Requested Date: | February 18, 2020 | |
Requested Time: | 8:30 a.m. Eastern Time (US) |
Dear Mr. Fischer:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned, on behalf of Biofrontera AG (the “Company”), respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 8:30 a.m. Eastern Time on February 18, 2020, or at such later time as the Company, acting through its counsel, McGuireWoods LLP, may request via a telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission.
Very truly yours, | |
/s/ Thomas Schaffer | |
Thomas Schaffer | |
Chief Financial Officer |
cc: | Stephen E. Older, Esq. |
Seth Goldsamt, Esq. |